Company intelligence / Profile preview

Ekso Bionics

San Rafael / Richmond / San Francisco Bay Area*, California, United Stateseksobionics.com ↗

Ownership: Public · EKSO
Employees: ~50
Development stage: Commercial

Overview

Ekso Bionics’ exoskeletons are FDA-cleared for use in stroke and spinal cord injury patients; the company’s devices are also cleared for acquired brain injury and multiple sclerosis. Clinical studies have demonstrated improved gait training outcomes and increased independence in neurological patient populations. The company’s products are used in over 400 centers globally.

Therapeutic areas: Neurology
Modalities: Device (wearable exoskeleton)Non-pharmacological therapy (robotic rehabilitation)
Industry: Assistive Medical Devices

Partnerships

Lockheed Martin (military HULC licensing)Parker Hannifin/Indego acquisition

Financials

Market cap: $38.6M
Total revenue: $2.1M
Enterprise value: $38.9M

Beyond the preview

Go deeper on Ekso Bionics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ekso Bionics.

Explore the full profile